Cargando…
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis
Lymphoma is listed among the neoplasias with a high risk of venous thromboembolism (VTE). Risk factors for VTE appear to differ from risk factors in solid tumors. We review the literature of the last 20 years for reports identifying these risk factors in cohorts consisting exclusively of lymphoma pa...
Autores principales: | Hohaus, Stefan, Bartolomei, Francesca, Cuccaro, Annarosa, Maiolo, Elena, Alma, Eleonora, D’Alò, Francesco, Bellesi, Silvia, Rossi, Elena, De Stefano, Valerio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281118/ https://www.ncbi.nlm.nih.gov/pubmed/32443753 http://dx.doi.org/10.3390/cancers12051291 |
Ejemplares similares
-
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization
por: Hohaus, Stefan, et al.
Publicado: (2018) -
Severe CMV Infection after Chemo-Immunotherapy with Dose-Reduced Bendamustine and Rituximab in a Mantle Cell Lymphoma Old Patient
por: Magliano, Gabriele, et al.
Publicado: (2021) -
Vitamin D deficiency and supplementation in patients with aggressive B‐cell lymphomas treated with immunochemotherapy
por: Hohaus, Stefan, et al.
Publicado: (2017) -
PD‐L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma
por: Cuccaro, Annarosa, et al.
Publicado: (2022) -
P1091: CLINICAL IMPLICATIONS OF T CELL SUBSET COMPOSITION DURING MAINTENANCE THERAPY AFTER FIRST-LINE IMMUNOCHEMOTHERAPY CONTAINING BENDAMUSTINE IN PATIENTS WITH FOLLICULAR LYMPHOMA
por: Malafronte, Rosalia, et al.
Publicado: (2023)